Anxiolytic Effect of a Novel 5-HT3 Receptor Antagonist (4-Phenylpiperazin-1-yl)(Quinoxalin-2-yl) Methanone (4a) in a Battery of Behavioral Models for Anxiety in Mice
No Thumbnail Available
Date
2013
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
The Pharma Innovation
Abstract
The serotonergic system of brain is well understood to play a crucial role in emotional processing in human and
animals. 5-HT3 receptor, the ion channel type of receptor is involved in mood, anxiety, depression, learning and
memory. Objective of the present work was to investigate the anxiolytic potential of a novel 5-HT3 receptor
antagonist (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a) in mice. Different behavioral test paradigms
for anxiety like elevated plus maze, open field test, light-dark model and hole board test were used for assessing the
effect. Diazepam 2 mg/kg i.p. served as a reference standard. From the results it was found that 4a dose dependently
at 2 and 4 mg/kg i.p. attenuated the behavioral alterations in the anxiety models in mice. The exact mechanism of 5-
HT3 receptor antagonist for anxiolytic potential is still ill understood. Our further studies will deal with mechanisms
at molecular levels for anxiolytic potential of 4a
Description
Keywords
Pharmacy, 5-HT3 Receptor, Anxiety, Elevated plus maze (EPM), Open field test (OFT)